Information Provided By:
Fly News Breaks for December 14, 2017
MDXG
Dec 14, 2017 | 08:55 EDT
Lake Street analyst Bruce Jackson believes shares of MiMedx Group are at an attractive entry point after the company's 2018 revenue guidance topped expectations. The analyst believes 2018 is shaping up favorably for MiMedx and he keeps a Buy rating on the shares with an $18 price target.